COVID–19 Emergency Medical Supplies Enhancement Act of 2021
USA117th CongressHR-3125| House
| Updated: 5/19/2021
Juan Vargas
Democratic Representative
California
Cosponsors (4)
Financial Services Committee, Banking, Housing, and Urban Affairs Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
COVID-19 Emergency Medical Supplies Enhancement Act of 2021 This bill expands certain authorities under the Defense Production Act of 1950 (DPA) and authorizes the President and federal agencies to take specific actions to support the production of critical medical supplies during the COVID-19 (i.e., coronavirus disease 2019) emergency, including with respect to private-sector coordination, needs assessments, and overall strategies. The bill makes loans under the DPA subject to certain notification requirements. A report required under the DPA for FY2022 and FY2023 shall include the percentage of contracts awarded to small businesses.
Suggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on Financial Services.
Mr. Cleaver moved to suspend the rules and pass the bill.
Considered under suspension of the rules. (consideration: CR H2456-2458)
DEBATE - The House proceeded with forty minutes of debate on H.R. 3125.
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H2456-2457)
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H2456-2457)
Motion to reconsider laid on the table Agreed to without objection.
Received in the Senate and Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
Government Operations and Politics
Administrative law and regulatory proceduresCardiovascular and respiratory healthCongressional oversightDrug therapyEmergency medical services and trauma careGovernment lending and loan guaranteesHealth promotion and preventive careHealth technology, devices, suppliesInfectious and parasitic diseasesManufacturingMedical tests and diagnostic methodsMilitary procurement, research, weapons developmentPublic contracts and procurementPublic-private cooperationSmall businessStrategic materials and reservesWorker safety and health
COVID–19 Emergency Medical Supplies Enhancement Act of 2021
USA117th CongressHR-3125| House
| Updated: 5/19/2021
COVID-19 Emergency Medical Supplies Enhancement Act of 2021 This bill expands certain authorities under the Defense Production Act of 1950 (DPA) and authorizes the President and federal agencies to take specific actions to support the production of critical medical supplies during the COVID-19 (i.e., coronavirus disease 2019) emergency, including with respect to private-sector coordination, needs assessments, and overall strategies. The bill makes loans under the DPA subject to certain notification requirements. A report required under the DPA for FY2022 and FY2023 shall include the percentage of contracts awarded to small businesses.
Suggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on Financial Services.
Mr. Cleaver moved to suspend the rules and pass the bill.
Considered under suspension of the rules. (consideration: CR H2456-2458)
DEBATE - The House proceeded with forty minutes of debate on H.R. 3125.
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H2456-2457)
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H2456-2457)
Motion to reconsider laid on the table Agreed to without objection.
Received in the Senate and Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
Juan Vargas
Democratic Representative
California
Cosponsors (4)
Financial Services Committee, Banking, Housing, and Urban Affairs Committee
Government Operations and Politics
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Administrative law and regulatory proceduresCardiovascular and respiratory healthCongressional oversightDrug therapyEmergency medical services and trauma careGovernment lending and loan guaranteesHealth promotion and preventive careHealth technology, devices, suppliesInfectious and parasitic diseasesManufacturingMedical tests and diagnostic methodsMilitary procurement, research, weapons developmentPublic contracts and procurementPublic-private cooperationSmall businessStrategic materials and reservesWorker safety and health